Impact of the selective estrogen receptor modulator, tamoxifen, on neuronal outgrowth and survival following toxic insults associated with aging and Alzheimer's disease
- 31 August 2004
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 188 (2) , 268-278
- https://doi.org/10.1016/j.expneurol.2004.01.014
Abstract
No abstract availableKeywords
Funding Information
- Kenneth T. and Eileen L. Norris Foundation
- American Foundation for Pharmaceutical Education
- National Institute on Aging (PO1 AG1475)
This publication has 50 references indexed in Scilit:
- The women's health initiative estrogen replacement therapy is neurotrophic and neuroprotectiveNeurobiology of Aging, 2000
- The selective oestrogen receptor modulation: evolution and clinical applicationsBritish Journal of Clinical Pharmacology, 1999
- Neues zum MammakarzinomGynäkologisch-geburtshilfliche Rundschau, 1999
- A Risk-Benefit Assessment of Tamoxifen TherapyDrug Safety, 1993
- Droloxifene, a new anti-oestrogen in postmenopausal advanced breast cancer: Preliminary results of a double-blind dose-finding phase II trialEuropean Journal Of Cancer, 1992
- Antitumor Effects of Droloxifene, a New Antiestrogen Drug, against 7,12-Dimethylbenz(a)anthracene-Induced Mammary Tumors in RatsThe Japanese Journal of Pharmacology, 1991
- Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: Problems and potential for future clinical applicationsBreast Cancer Research and Treatment, 1983
- Oestrogen-responsive human breast cancer in long term tissue cultureNature, 1975
- Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptorPublished by Elsevier ,1975
- A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474British Journal of Cancer, 1971